Rosemary Shy

1.4k total citations
17 papers, 310 citations indexed

About

Rosemary Shy is a scholar working on Cellular and Molecular Neuroscience, Neurology and Genetics. According to data from OpenAlex, Rosemary Shy has authored 17 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 5 papers in Neurology and 4 papers in Genetics. Recurrent topics in Rosemary Shy's work include Hereditary Neurological Disorders (11 papers), Botulinum Toxin and Related Neurological Disorders (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Rosemary Shy is often cited by papers focused on Hereditary Neurological Disorders (11 papers), Botulinum Toxin and Related Neurological Disorders (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Rosemary Shy collaborates with scholars based in United States, Australia and Italy. Rosemary Shy's co-authors include Michael E. Shy, Joshua Burns, Davide Pareyson, Francesco Muntoni, Richard S. Finkel, Matilde Laurá, Mary M. Reilly, Tim Estilow, Robert Ouvrier and Gyula Acsádi and has published in prestigious journals such as Neurology, Annals of Neurology and Clinical Biomechanics.

In The Last Decade

Rosemary Shy

15 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosemary Shy United States	8	245	121	60	43	40	17	310
Mariola Skorupinska United Kingdom	7	127 0.5×	57 0.5×	26 0.4×	38 0.9×	14 0.3×	20	193
Riccardo Zuccarino Italy	9	136 0.6×	126 1.0×	49 0.8×	34 0.8×	19 0.5×	18	224
Tim Estilow United States	5	140 0.6×	79 0.7×	40 0.7×	21 0.5×	28 0.7×	12	178
T. Naegele Germany	5	116 0.5×	137 1.1×	97 1.6×	40 0.9×	20 0.5×	6	365
Yoshimitsu Shimatani Japan	13	170 0.7×	282 2.3×	125 2.1×	33 0.8×	7 0.2×	31	434
Fabrizio Gaudiello Italy	11	174 0.7×	70 0.6×	88 1.5×	117 2.7×	9 0.2×	14	289
Matthew Wicklund United States	12	127 0.5×	111 0.9×	83 1.4×	23 0.5×	28 0.7×	34	412
Mark T. Rogers United Kingdom	9	143 0.6×	57 0.5×	54 0.9×	49 1.1×	16 0.4×	11	279
Frédérique Audic France	9	58 0.2×	63 0.5×	40 0.7×	31 0.7×	11 0.3×	23	177
Anne Kjersti Erichsen Norway	8	222 0.9×	58 0.5×	73 1.2×	103 2.4×	23 0.6×	12	297

Countries citing papers authored by Rosemary Shy

Since Specialization

Citations

This map shows the geographic impact of Rosemary Shy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Shy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Shy more than expected).

Fields of papers citing papers by Rosemary Shy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Shy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Shy. The network helps show where Rosemary Shy may publish in the future.

Co-authorship network of co-authors of Rosemary Shy

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Shy. A scholar is included among the top collaborators of Rosemary Shy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Shy. Rosemary Shy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Shy, Rosemary, Shawna Feely, Kayla Cornett, et al.. (2025). Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT. Journal of the Peripheral Nervous System. 30(2). e70029–e70029.

Cornett, Kayla, Sarah P. Garnett, Rosemary Shy, et al.. (2023). Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease. Neurology. 101(7). e717–e727. 3 indexed citations

Cornett, Kayla, Manoj P. Menezes, Paula Bray, et al.. (2020). Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS. Annals of Clinical and Translational Neurology. 7(9). 1713–1715. 15 indexed citations

Zuccarino, Riccardo, Valeria Prada, Isabella Moroni, et al.. (2020). Validation of the Italian version of the Charcot‐Marie‐Tooth disease Pediatric Scale. Journal of the Peripheral Nervous System. 25(2). 138–142. 6 indexed citations

Eichinger, Katy, Joshua Burns, Kayla Cornett, et al.. (2018). The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM). Neurology. 91(15). e1381–e1384. 26 indexed citations

Cornett, Kayla, Manoj P. Menezes, Rosemary Shy, et al.. (2017). Natural history of Charcot‐Marie‐Tooth disease during childhood. Annals of Neurology. 82(3). 353–359. 51 indexed citations

Burns, Joshua, Manoj P. Menezes, Richard S. Finkel, et al.. (2013). Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot‐Marie‐Tooth disease. Journal of the Peripheral Nervous System. 18(2). 177–180. 15 indexed citations

Sanmaneechai, Oranee, et al.. (2013). THE CHARCOT-MARIE-TOOTH (CMT) DISEASE INFANT-TODDLER SCALE: DEVELOPING SCORING SYSTEM AND PILOT STUDY TESTING THE ABILITY OF THE SCALE TO ASSESS DISEASE SEVERITY IN INFANTS, TODDLERS AND SEVERELY AFFECTED CHILDREN WITH CMT. 1 indexed citations

Burns, Joshua, Robert Ouvrier, Tim Estilow, et al.. (2012). Validation of the Charcot–Marie–Tooth disease pediatric scale as an outcome measure of disability. Annals of Neurology. 71(5). 642–652. 124 indexed citations

10.

Burns, Joshua, Robert Ouvrier, Tim Estilow, et al.. (2012). Symmetry of foot alignment and ankle flexibility in paediatric Charcot–Marie–Tooth disease. Clinical Biomechanics. 27(7). 744–747. 13 indexed citations

11.

Shy, Michael E., Tim Estilow, Julie Pallant, et al.. (2012). Validation of the Charcot-Marie-Tooth Pediatric Scale as an Outcome Measure of Disability (P05.142). Neurology. 78(Meeting Abstracts 1). P05.142–P05.142. 1 indexed citations

12.

Burns, Joshua, Richard S. Finkel, Tim Estilow, et al.. (2011). Development, reliability and validity of the Charcot‐Marie‐Tooth disease Pediatric Scale (CMTPedS). Journal of Foot and Ankle Research. 4(S1). 1 indexed citations

13.

Li, J., et al.. (2007). Stoichiometric alteration of PMP22 protein determines the phenotype of HNPP. Journal of the Peripheral Nervous System. 12. 52–52. 3 indexed citations

14.

Shy, Rosemary. (2007). Tinea Corporis and Tinea Capitis. Pediatrics in Review. 28(5). 164–174. 2 indexed citations

15.

Li, Jun, et al.. (2007). Stoichiometric Alteration of PMP22 Protein Determines the Phenotype of Hereditary Neuropathy With Liability to Pressure Palsies. Archives of Neurology. 64(7). 974–974. 27 indexed citations

16.

Seth, Divya, Sanjay Chawla, Rosemary Shy, & Deepak Kamat. (2007). Dysphonia. Clinical Pediatrics. 46(3). 283–289. 1 indexed citations

17.

Shy, Rosemary. (2007). Tinea Corporis and Tinea Capitis. Pediatrics in Review. 28(5). 164–174. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact